No Data
No Data
Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a 212Pb-labeled Radio-DARPin Therapeutic Targeting DLL3 for Small Cell Lung Cancer Co-developed With Orano Med, at EANM 2024
Molecular Partners H1 Net Loss Narrows, Revenue Rises
Express News | Molecular Partners Adjusted H1 EPS $(0.88), Sales $4.75M
Molecular | 6-K: Report of foreign private issuer (related to financial reporting)
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
No Data
No Data